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RNA polymerase II (RNAPII) transcribes genes in a chromatin
context. We have designed a system to investigate the role of
chromatin remodelling during elongation in vivo, which involves
inserting a strong nucleosome-positioning sequence between
a promoter and a reporter gene. Our data indicate that a
nucleosome positioned in the body of a transcription unit impairs
RNAPII progression, provokes RNAPII accumulation upstream to
the positioned nucleosome and reduces transcription. By using
this system, we show that BRG1, the enzymatic motor of the
SWI–SNF chromatin-remodelling complex, is recruited to the
positioned nucleosome in a transcription elongation-dependent
manner and facilitates traversal of the nucleosome by RNAPII.
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INTRODUCTION
The basic building block of chromatin is the nucleosome, which
consists of about 150 bp of DNA wrapped around a histone
octamer containing two units of each of the histones H2A, H2B,
H3 and H4 (Luger et al, 1997). Enzymatic machines that travel
along the DNA have to deal with its compact nucleoprotein
organization. Biochemical studies in vitro have demonstrated that
nucleosomes form a high barrier for transcribing RNA polymerase
II (RNAPII; Izban & Luse, 1991; Bondarenko et al, 2006; Kulaeva
et al, 2007; Hodges et al, 2009). Thus, nucleosomes increase the
chance that RNAPII will pause at intrinsic transient pause sites at
which RNAPII would eventually arrest, even in naked DNA.
Furthermore, some of these in vitro studies have shown that
RNAPII elongation provokes the displacement of an H2A–H2B
dimer which generates a hexasome, but does not change
the position of the nucleosome on the DNA. In vivo experiments
have shown a negative correlation between RNAPII-dependent
transcription and density of histones, especially H2A and H2B, in
the body of the gene (Thiriet & Hayes, 2005). However, direct
in vivo evidence of RNAPII blocking due to a nucleosome barrier
at the transcribed region of a gene has not been reported.
ATP-dependent chromatin-remodelling machines are able to
destabilize the interactions between DNA and histone octamers
(for a review, see Clapier & Cairns, 2009). Although the role
of these enzymes in chromatin remodelling at promoters and
regulatory regions has been extensively documented, their role
during elongation remains poorly understood. Workman and
colleagues demonstrated that a purified RSC complex, one of
the two switch–sucrose non-fermentable (SWI–SNF)-related
complexes from yeast, facilitates RNAPII elongation on a mono-
nucleosome template in vitro (Carey et al, 2006). However, it is
unclear whether SWI–SNF is required to help RNAPII overcome a
nucleosomal barrier at the body of the genes, in vivo. To explore
this issue, we have developed a system based on autonomously
replicating episomal plasmid, to investigate the role of a high
nucleosomal barrier in transcription elongation. We show that
strong nucleosome-positioning sequences impair transcriptional
elongation and provoke an accumulation of elongating polymerase
upstream to the nucleosomal barrier. Brahma-related gene 1
(BRG1), the ATPase subunit of the human SWI–SNF complex,
helps RNAPII to overcome this nucleosomal barrier.
RESULTS
Description of the reporter system
A system for in vivo study of the involvement of chromatin
remodelling during transcription elongation was generated using
pREP4-Luc episomal reporter vector. pREP4 contains Epstein–Barr
virus replication origin and encodes nuclear antigen 1 (Langle-
Rouault et al, 1998). This episomal vector has been shown
previously to form a correct nucleosomal chromatin structure
on transfection (van der Vlag et al, 2000). Our experimental
design involved the insertion of a sequence that strongly positions
a nucleosome between a promoter and a reporter luciferase
gene (Fig 1A). Two non-related nucleosome-positioning se-
quences were used: a fragment of the 5S ribosomal RNA
gene from Lytechinus variegatus (FitzGerald & Simpson, 1985)
and the 601 sequence (Lowary & Widom, 1998). Both of these
sequences have been extensively characterized, and have strong
nucleosome-positioning abilities. As a control sequence, we used
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a fragment of bacterial ampicillin resistance gene of the same
length as the nucleosome sequences (CtSq5S and CtSq601), 195
and 147 bp, respectively. Sequences were placed downstream to
an approximately 1.2-kb translation elongation factor 1a (EF1a)
gene fragment including the promoter, exon 1, intron 1 and
9 bp of exon 2 of the gene (Fig 1A; Uetsuki et al, 1989). Finally,
the Luciferase gene was placed downstream to the nucleosome
positioning and control sequences. Therefore, four transcriptional
units were generated, termed EF1a-5S-Luc, EF1a-CtSq5S-Luc,
EF1a-601-Luc and EF1a-CtSq601-Luc. The messenger RNA generated
from these transcriptional units included exon 1 and nine bases of
exon 2 of EF1a, the positioning or control sequences and the
luciferase sequence (data not shown). Constructs without the
EF1a fragment were also generated as controls (Fig 1A).
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Fig 1 | A system to study the role of nucleosome-positioning during transcription elongation, in vivo. (A) Schematic representation of the transcription
units inserted into the pREP4 plasmids. (B,C) Line graphs of nucleosomal positioning at the indicated transcription units in vivo. Constructs
containing the indicated transcription units were transfected into 293T cells. Twenty-four hours after transfection cells were treated with 2mg/ml
a-amanitin (see supplementary Fig S2 online) or non-treated, for an additional 24 h before chromatin isolation. The mapping of nucleosomal positions
by MNase and qPCR is described in the supplementary information online. The position of nucleosomes deduced from the data are represented as
solid line ovals. Black lines under representation denote the locations of amplicons for qPCR analysis. Numbers in the x-axis correspond to nucleotide
positions with respect to the transcription start point. Data are means of three independent experiments and error bars represent ±s.d. values.
EF1a, elongation factor 1a; qPCR, quantitative PCR.
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First, we confirmed in vivo positioning of the nucleosomes at
the 5S and 601 episomal constructs. Cells were fixed with
formaldehyde and nuclei were obtained. After micrococcal
nuclease (MNase) digestion, mononucleosomal DNA was isolated
(supplementary Fig S1 online) and subjected to quantitative
PCR (qPCR), using primer pairs that cover 700 bp around the
positioning or the control sequences. The results were normalized
against those obtained using MNase-digested genomic DNA.
There was a strong decrease in MNase sensitivity at the 5S and
601 sequences, indicating the presence of a strongly positioned
nucleosome (Fig 1B,C). Some nucleosome enrichment was
also observed upstream and downstream from the 5S and
601 sequences, suggesting the presence of less stably positioned
nucleosomes. As expected, nucleosome enrichment was low
or absent at control sequences. Transcription inhibition with
a-amanitin increased nucleosome occupancy, indicating that
transcription is accompanied by nucleosome remodelling. As a
control, we checked that a-amanitin blocks transcription
and strongly decreases occupancy of RNAPII from the 5S and
601 elements of the EF1a-5S-Luc and EF1a-601-Luc transcription
units (supplementary Fig S2A,B,C online).
A positioned nucleosome impairs RNAPII progression
We then analysed whether 5S and 601 nucleosomal positioning
sequences affect expression of the luciferase reporter gene.
Constructs containing nucleosome-positioning sequences showed
significantly lower (4–5-fold) luciferase activity levels than control
constructs (Fig 2A). Nucleosomes have been shown to represent
a strong barrier for RNAPII traversal in vitro (for a review,
see Kulaeva et al, 2007). Therefore, a possible explanation
of our result was that the decrease in luciferase activity was a
consequence of a defect in transcription elongation. We reasoned
that, if transcription elongation was impaired by the positioned
nucleosome, truncated transcripts containing sequences upstream
to the positioning sequences should accumulate. An accumulation
of transcripts of the EF1a-5S-Luc and EF1a-601-Luc transcription
units containing sequences upstream to the positioning sequences
was observed (Fig 2B,C), suggesting that the positioned
nucleosome had impaired RNAPII progression.
Next, in chromatin immunoprecipitation (ChIP) experiments,
we analysed RNAPII occupancy along the transcription
units. RNAPII was evenly distributed along the transcription units
that lacked nucleosome-positioning sequences (Fig 3). However,
when transcription units containing nucleosome-positioning
sequences were analysed, a significant accumulation of RNAPII
was observed upstream to these sequences. Concomitantly, a
reduction in RNAPII occupancy was observed in the luciferase
region (Fig 3B,C). Similar results were obtained using an antibody
that specifically recognizes the elongating form of RNAPII
(data not shown). Transcription units with and without positioned
nucleosomes have very different profiles of RNAPII occupancy.
This strongly suggests that RNAPII elongation is being blocked,
in vivo, by the nucleosomal barrier.
BRG1 facilitates nucleosome traversal by RNAPII
We used the system described above to investigate the role
of BRG1—one of the ATPases of the mammalian SWI–SNF
complexes—in chromatin remodelling during elongation. First,
we determined by using ChIP analysis whether endogenous BRG1
is recruited to the transcribed region within the EF1a-5S-Luc and
EF1a-CtSq5S-Luc transcription units (Fig 4A). A high level of BRG1
enrichment was observed at the 5S and EF1a intron regions of the
EF1a-5S-Luc transcription unit, but not at the EF1a-CtSq5S-Luc
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Fig 2 | Nucleosome-positioning impairs transcription. (A) Constructs
containing the indicated transcription units were transfected into 293T
cells. Forty-eight hours after transfection, cells were collected and Luc
activity was measured. Data are expressed as a percentage of mean
relative activity from three independent experiments. Error bars
represent ±s.d. values. (B) Schematic representation of the indicated
transcription units with the locations of amplicons for RT–qPCR
analysis. (C) Constructs containing the indicated transcription units were
transfected into 293T cells. Forty-eight hours after transfection RNA
expression was analysed by using RT–qPCR with primers specific for the
50 and 30 amplicons. Data are means of three independent experiments
and error bars represent ±s.d. values. EF1a, elongation factor 1a;
RT–qPCR, reverse transcriptase–quantitative PCR.
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transcription unit (Fig 4A). Furthermore, recruitment of BRG1
was dependent on the presence of the EF1a promoter and
was significantly impaired in the presence of a-amanitin, which
blocks both transcription initiation and elongation (Bushnell et al,
2002), or in the presence of 5,6-dichlorobenzimidazole
1-b-D-ribofuranoside, which blocks elongation (Chodosh et al,
1989; Fig 4B), indicating that BRG1 recruitment requires transcrip-
tion. These data suggest that BRG1 escorts RNAPII during
elongation and is stabilized at regions with a high density of
positioned nucleosomes.
The involvement of BRG1 in transcription elongation was
explored by testing the effect of overexpressing BRG1 or a
dominant-negative BRG1 form (dnBRG1), containing a mutation
in the ATP-binding site domain on luciferase activity (de La Serna
et al, 2000). First, we confirmed by PCR that expression of BRG1
or dnBRG1 did not affect the number of copies of the episomal
vectors (data not shown). Second, we verified that BRG1 did
not alter initiation of transcription from the EF1a promoter in our
system (supplementary Fig S3 online). Consistent with the lack of
effect on transcription initiation, overexpression of wild-type
BRG1 or dnBRG1 did not affect the luciferase activity levels
reached by control sequence vectors (Fig 4C,D). However, BRG1
enhanced the EF1a-dependent luciferase activity observed with
5S and 601 nucleosome-positioning constructs. By contrast, a
dnBRG1 form impaired the EF1a-dependent luciferase activity of
episomal vectors containing 5S and 601 sequences (Fig 4C,D).
Together, these results suggest that BRG1 is involved in over-
coming the 5S and 601 nucleosomal barriers during transcription
elongation. Next, we assayed the role of BRG1 in C33A cells, a
cervical carcinoma cell line that contains very small amounts of
BRG1 and non-detectable amounts of the BRG1 paralogue human
BRAHMA (Muchardt & Yaniv, 1993; Dunaief et al, 1994). In these
cells, BRG1 strongly enhanced the expression of EF1a-5S-Luc
(14-fold) and the EF1a-601-Luc (ninefold) transcription units, but
not of transcription units, containing control sequences (Fig 4E).
Next, we wondered how BRG1 affects RNAPII distribution in
our system. Expression of BRG1 in C33A cells provoked a
significant reduction in the level of RNAPII accumulated upstream
to or at the nucleosome-positioning sequence in the EF1a-5S-Luc
transcription unit (Fig 5A). These data suggest that BRG1 helps
elongating RNAPII to overcome the barrier created by the
positioned nucleosome. Finally, we showed that expression
of dnBRG1 in 293T cells strongly reduced MNase accessibility of
the positioned nucleosome at the EF1a-5S-Luc transcription unit
(Fig 5B, left panel, compare lanes 6–7 and 8–9), suggesting that
the SWI–SNF complex is responsible for the remodelling of this
nucleosome during elongation. Consistent with the fact that BRG1
is recruited in a transcription-dependent manner, expression
of dnBRG1 had no effect on the 5S-Luc transcription unit
that lacks the EF1a promoter (Fig 5B, left panel, compare lanes
2–3 and 4–5).
DISCUSSION
In this study, we show that a positioned nucleosome in the body of
a transcription unit impairs RNAPII progression in vivo and, as a
consequence, provokes a reduction of transcription. Furthermore,
we show that BRG1, the ATPase of the SWI–SNF complex, is
recruited to the positioned nucleosome and helps RNAPII to
overcome the nucleosomal barrier.
To rule out possible sequence effects, two different nucleo-
some-positioning sequences were used, and similar results were
obtained with both of them. Interestingly, 601 sequence displays
a much higher affinity for the octamer than 5S in in vitro
nucleosome reconstitution assays (Lowary & Widom, 1998),
but both showed a similar blocking effect in our in vivo assays.
These data suggest that other chromatin-associated aspects, in
addition to DNA-histone octamer affinity, affect the strength of the
transcriptional blockage in vivo. For example, we cannot rule out
the possibility that, in addition to DNA–histone octamer affinity,
other factors are different between 601, 5S and other random
nucleosomes and these might be affecting the rate of transcription.
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These include nucleosomal restoration behind advancing RNAPII,
degree of histone modification or association to other chromatin
structural factors.
In a series of elegant studies, Kingston and co-workers showed
that the SWI–SNF complex is involved in the heat-shock factor
protein 1-dependent activation of elongation of a promoter-
proximal paused RNAPII at the mouse hsp70 gene (Brown et al,
1996; Sullivan et al, 2001). Now, we show that SWI–SNF
facilitates the progression of RNAPII through nucleosomes during
productive elongation in the middle of a transcription unit.
The mechanism by which the SWI–SNF complex enables
RNAPII to overcome a nucleosomal barrier is unknown. Nucleo-
somes spontaneously undergo conformational fluctuations in
which a stretch of their DNA transiently lifts off the histone
surface (unwrapping; Li et al, 2005). In vitro studies carried out
by Hodges et al, (2009) have recently reported that RNAPII does
not seem to actively unwrap nucleosomes, but instead waits for
these fluctuations spontaneous to occur. The SWI–SNF complex
might help RNAPII by increasing the frequency or extent of these
fluctuations. Thus, the transiently remodelled state provoked by
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the SWI–SNF complex would open a ‘window of opportunity’ for
RNAPII to cross the nucleosome. Does RNAPII require SWI–SNF
to pass through every nucleosome? Even in vitro, nucleosomes are
not an insurmountable barrier to elongation (Izban & Luse, 1991).
Loosely positioned nucleosomes display a low core histone–DNA
affinity and might adopt several positions, which represent a low
barrier for RNAPII. We show that BRG1 was specifically required
to increase transcription of templates with positioned nucleo-
somes. Furthermore, BRG1 occupancy was higher near to the
strongly positioned nucleosome sequence. Therefore, we propose
that traversal of RNAPII through strongly positioned nucleosomes
is more dependent on the SWI–SNF complex than traversal
of loosely positioned nucleosomes.
METHODS
Cell lines and culturing conditions. The 293T and C33A cell lines
were routinely grown in Dulbecco’s modified Eagle’s medium,
supplemented with 7% fetal bovine serum, 100 U/ml penicillin
and 100 mg/ml streptomycin.
Immunoblotting and antibodies. RNAPII (N-20, sc-899) and
BRG1 (H-88, sc-10768) antibodies were obtained from Santa
Cruz Biotechnology; g-tubulin antibody from Sigma. Immunoblot-
ting was carried out using standard procedures (see supplementary
information online).
MNase digestion. Preparation of mononucleosomes by MNase
digestion and analysis of nucleosomal positioning in vivo are
described in detail in the supplementary information online.
Briefly, 48 h after transfection, proteins were cross-linked to DNA
by the addition of formaldehyde. Then, the cross-linking reaction
was stopped by adding glycine, and nuclei were isolated and
digested with MNase (supplementary Fig S1A online). To normalize,
naked DNA was also digested with MNase (supplementary
Fig S1B online). Then, DNA was extracted and equal amounts
were run in a 1.2% agarose gel and visualized with ethidium
bromide (supplementary Fig S1C,D online). The band correspond-
ing to mononucleosome size (B160 bp) was excised from the gel
and DNA was purified. Equal amounts of DNA were used as a
template for real-time PCR (qPCR) with the Applied Biosystems
7500 FAST Real-Time PCR System. The qPCR results were then
normalized to the GFP gene qPCR as transfection control and to
the MNase-digested naked DNA to avoid MNase digestion bias.
Sequences of all oligonucleotides used for MNase mapping are
listed in supplementary Table S1 online.
ChIP assays. The ChIP assays were performed as described
previously (Strutt & Paro, 1999). Briefly, chromatin was sonicated
to an average fragment size of 400–500 bp using Diagenode
Bioruptor. Rabbit- or mouse-purified IgG (Sigma) was used as a
control for nonspecific interaction of DNA. The human ACTB
gene amplicon was used as a control for nonspecific binding of
genomic DNA to beads or IgGs, and GFP gene PCR was used for
transfection control. Quantification of immunoprecipitated DNA
was performed by qPCR. At least three independent experiments
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were carried out. Each sample was quantified using three real-time
PCR determinations. Sequences of all oligonucleotides used for
ChIP are listed in supplementary Table S2 online.
Luciferase reporter assays. Luciferase activity was determined
with a luciferase assay kit (Promega), according to the manufac-
turer’s instructions.
RNA extraction and reverse transcriptase–qPCR. Total RNA was
prepared by using the RNAsy Kit (Qiagen), as described in the
manufacturer’s instructions. Quantification of gene products was
performed by qPCR. Oligonucleotides used in reverse transcription–
qPCR experiments are listed in supplementary Table S2 online.
Additional experimental procedures are described in the
supplementary information online.
Supplementary information is available at EMBO reports online
(http://www.emboreports.org).
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